Switching to a TAF-based or to TDF-sparing (dual combination, DC) regimens is considered as safer than continuing to take TDF-containing regimens, particularly for bone/kidney health. The main aim of this analysis was to evaluate the possible impact of recent results from randomised studies, which led to a change in treatment guidelines, on the observed rate of switch from TDF to TAF-based regimens or TDF-sparing DC in real-life and to identify the determinants of switch separately for the two strategies, with focus on current eGFR values.

Determinants of switching to TAF-based cART or dual combinations (DC) from TDF-based regimens in a cohort of HIV-infected individuals with controlled viral load <50 copies/mL.

G. Nunnari;G. F. Pellicanò.
2019-01-01

Abstract

Switching to a TAF-based or to TDF-sparing (dual combination, DC) regimens is considered as safer than continuing to take TDF-containing regimens, particularly for bone/kidney health. The main aim of this analysis was to evaluate the possible impact of recent results from randomised studies, which led to a change in treatment guidelines, on the observed rate of switch from TDF to TAF-based regimens or TDF-sparing DC in real-life and to identify the determinants of switch separately for the two strategies, with focus on current eGFR values.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11570/3147223
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
social impact